Pimobendan
In stock and ready to ship.
RX Required
Vetmedin (pimobendan) is the first-line prescription treatment for congestive heart failure (CHF) in dogs caused by the two most common canine heart diseases — mitral valve disease (MMVD) and dilated cardiomyopathy (DCM). It helps a weakened heart pump more efficiently, improving quality of life and, in studies, extending the time dogs live comfortably with heart disease.
Pimobendan is an "inodilator" — it does two jobs at once: it strengthens the heart muscle's contractions (positive inotrope) and gently widens the blood vessels the heart pumps against (vasodilator). The result is more effective circulation with less effort from the heart.
Vetmedin chewable tablets come in 1.25 mg, 2.5 mg, 5 mg and 10 mg strengths. The label dose is a total of 0.5 mg/kg per day, split into two doses given about 12 hours apart, roughly one hour before food. Heart medication plans are individual — always follow the exact strength and schedule your veterinarian prescribes, and never stop or adjust it without their guidance.
Vetmedin is generally well tolerated; the most commonly reported effects are mild digestive upset or reduced appetite. It's used as part of an overall cardiac plan — your vet may combine it with diuretics or other heart medications and will schedule regular re-checks to fine-tune the plan.
Twice a day, about 12 hours apart, ideally an hour before meals. The chewable tablets are flavoured and most dogs take them readily.
No — improvement means the medication is working. Stopping can cause rapid decline; only change the plan under your veterinarian's direction.
Ask your veterinarian — where a generic is available and appropriate, your pharmacist will offer the option at checkout.
Yes. A licensed pharmacist verifies your vet's prescription before dispensing — upload your Rx here.
Prescription required. This information summarizes the manufacturer's label and is not a substitute for veterinary advice — always follow your veterinarian's directions. Vetmedin is a trademark of Boehringer Ingelheim Vetmedica.